Home
ONCY
ONCY News

Latest Oncolytics Biotech Inc. (ONCY) News on December 18, 2024

MT Newswires

6 hours ago

Oncolytics Biotech to Present "Promising" Pelareorep Data at ASCO GI Symposium

Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium

PR Newswire

7 hours ago

Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium

MT Newswires

15 days ago

Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

CNW Group

15 days ago

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com

a month ago

Oncolytics Biotech Inc (ONCY) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

MT Newswires

a month ago

Oncolytics Biotech Q3 Loss Narrows

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

PR Newswire

a month ago

Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

PR Newswire

a month ago

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

CNW Group

a month ago

Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights

ONCY Stock Up on Regulatory Update From Breast Cancer Program

Zacks

2 months ago

ONCY Stock Up on Regulatory Update From Breast Cancer Program

Oncolytics targets accelerated approval for oncolytic virus therapy

Pharmaceutical Technology

2 months ago

Oncolytics targets accelerated approval for oncolytic virus therapy

MT Newswires

2 months ago

Oncolytics Biotech Provides Clinical Updates

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

CNW Group

2 months ago

Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

MT Newswires

3 months ago

Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

PR Newswire

3 months ago

Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

CNW Group

3 months ago

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

PR Newswire

3 months ago

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Sernova Corp. Announces Appointment of New Chief Executive Officer

GlobeNewswire

4 months ago

Sernova Corp. Announces Appointment of New Chief Executive Officer

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

PR Newswire

5 months ago

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

MT Newswires

5 months ago

Oncolytics Biotech Reports Q2 Loss of $7.5 Million

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights

CNW Group

5 months ago

Oncolytics Biotech® Reports Second Quarter 2024 Financial Results and Operational Highlights

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

CNW Group

5 months ago

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

MT Newswires

6 months ago

Oncolytics Biotech UP 1.9% In US Premarket Announces "Productive" FDA Type C Meeting on Metastatic Breast Cancer Program

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

CNW Group

6 months ago

Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

MT Newswires

6 months ago

Oncolytics Biotech CEO Matt Coffey to Take Medical Leave of Absence

MT Newswires

6 months ago

Oncolytics Biotech President and CEO Coffey to Take Medical Leave of Absence

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

PR Newswire

6 months ago

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

Oncolytics doses first subject in pancreatic cancer trial

Clinical Trials Arena

6 months ago

Oncolytics doses first subject in pancreatic cancer trial

MT Newswires

6 months ago

Oncolytics Biotech Doses First Patient in Pelareorep Study Involving Modified FOLFIRINOX

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

PR Newswire

6 months ago

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

6 months ago

Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

MT Newswires

7 months ago

Oncolytics Biotech Says ASCO Abstracts Highlight Pelareorep's Treatment Potential in Pancreatic Cancer

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

CNW Group

7 months ago

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

PR Newswire

7 months ago

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

MT Newswires

7 months ago

Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

CNW Group

7 months ago

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript

MT Newswires

7 months ago

Oncolytics Biotech Reports a First-Quarter Loss of Near $7 Million

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

PR Newswire

7 months ago

Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

MT Newswires

7 months ago

Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

CNW Group

7 months ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

PR Newswire

7 months ago

Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

PR Newswire

7 months ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

CNW Group

7 months ago

Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

CNW Group

8 months ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

PR Newswire

8 months ago

Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

PR Newswire

8 months ago

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

PR Newswire

8 months ago

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

CNW Group

8 months ago

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

CNW Group

9 months ago

Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

CNW Group

9 months ago

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Newsfile

9 months ago

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

CNW Group

9 months ago

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

CNW Group

9 months ago

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

CNW Group

10 months ago

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

PR Newswire

10 months ago

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Simply Wall St.

10 months ago

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Newsfile

10 months ago

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

CNW Group

10 months ago

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire

a year ago

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

ISG to Publish Reports on Google Cloud Ecosystem

Business Wire

a year ago

ISG to Publish Reports on Google Cloud Ecosystem

Community West Bancshares Reports Full Year Earnings Amid Merger Developments

GuruFocus.com

a year ago

Community West Bancshares Reports Full Year Earnings Amid Merger Developments

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

InvestorPlace

a year ago

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

Here's Why DHI Group (NYSE:DHX) Has Caught The Eye Of Investors

Simply Wall St.

a year ago

Here's Why DHI Group (NYSE:DHX) Has Caught The Eye Of Investors

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

Simply Wall St.

a year ago

BCB Bancorp, Inc. (NASDAQ:BCBP) most popular amongst retail investors who own 51% of the shares, institutions hold 36%

GuruFocus.com

a year ago

BCB Bancorp Inc (BCBP) Reports Decline in Q4 Earnings and Announces Dividend

Compared to Estimates, BCB Bancorp (BCBP) Q4 Earnings: A Look at Key Metrics

Zacks

a year ago

Compared to Estimates, BCB Bancorp (BCBP) Q4 Earnings: A Look at Key Metrics

Strength Seen in Flux Power Holdings, Inc. (FLUX): Can Its 8.4% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Flux Power Holdings, Inc. (FLUX): Can Its 8.4% Jump Turn into More Strength?

Provident Financial Holdings To Host Earnings Release Conference Call

GlobeNewswire

a year ago

Provident Financial Holdings To Host Earnings Release Conference Call

Hyliion to Participate in POWERGEN International Conference

Business Wire

a year ago

Hyliion to Participate in POWERGEN International Conference

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

PR Newswire

a year ago

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

China Automotive Systems (NASDAQ:CAAS) Is Doing The Right Things To Multiply Its Share Price

Simply Wall St.

a year ago

China Automotive Systems (NASDAQ:CAAS) Is Doing The Right Things To Multiply Its Share Price

C&F Financial (NASDAQ:CFFI) shareholders have earned a 19% CAGR over the last three years

Simply Wall St.

a year ago

C&F Financial (NASDAQ:CFFI) shareholders have earned a 19% CAGR over the last three years

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

PR Newswire

a year ago

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

CNW Group

a year ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

PR Newswire

a year ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

Business Wire

a year ago

Tilly’s, Inc. Announces 2023 Holiday Period Net Sales, Updates Fourth Quarter Outlook

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

ACCESSWIRE

a year ago

Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

GlobeNewswire

a year ago

ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

CNW Group

a year ago

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

Xeris Biopharma Updates Its Outlook for 2023

Business Wire

a year ago

Xeris Biopharma Updates Its Outlook for 2023

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

PR Newswire

a year ago

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

RETRANSMISSION: HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Newsfile

a year ago

RETRANSMISSION: HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Newsfile

a year ago

HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

GuruFocus.com

a year ago

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

Geospace Technologies Sells $30M in Ocean Bottom Nodes

Business Wire

a year ago

Geospace Technologies Sells $30M in Ocean Bottom Nodes

Emeren Group Releases 2022 Environmental, Social and Governance Report

PR Newswire

a year ago

Emeren Group Releases 2022 Environmental, Social and Governance Report

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

InvestorPlace

a year ago

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

Smith-Midland Appoints New Members to its Board of Directors

ACCESSWIRE

a year ago

Smith-Midland Appoints New Members to its Board of Directors

Business Wire

a year ago

Tilly’s, Inc. Announces Participation in ICR Conference 2024

L.B. Foster Company Announces the Expansion of its Board of Directors and Election of David J. Meyer

GlobeNewswire

a year ago

L.B. Foster Company Announces the Expansion of its Board of Directors and Election of David J. Meyer

Despite Fast-paced Momentum, Willdan (WLDN) Is Still a Bargain Stock

Zacks

a year ago

Despite Fast-paced Momentum, Willdan (WLDN) Is Still a Bargain Stock

12 Extreme Dividend Stocks With Upside Potential

Insider Monkey

a year ago

12 Extreme Dividend Stocks With Upside Potential

AFC Gamma Announces Fourth Quarter 2023 Dividend

GlobeNewswire

a year ago

AFC Gamma Announces Fourth Quarter 2023 Dividend

Marketing Dive

a year ago

Trivago introduces brand refresh with ads localized with help from AI

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

Zacks

a year ago

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

SCALINX and Arteris Partner on Advanced Communications Innovation

GlobeNewswire

a year ago

SCALINX and Arteris Partner on Advanced Communications Innovation

Share on Social Networks: